Yvonne J. Summers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yvonne J. Summers has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Clare M. Heyworth
CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
1 shared publicationErika A. de Wynter
CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
1 shared publicationJames Chang
CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
1 shared publicationNydia G. Testa
CRC Experimental Haematology Group, Paterson Institute for Cancer Research, Manchester, United Kingdom
1 shared publication
Latest Publications
- 1 November 2001
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 19 (6) , 505-513
Cord Blood G0CD34+Cells Have A Thousand‐Fold Higher Capacity For Generating Progenitors In Vitro Than G1CD34+Cells
We examined the functional differences between G(0) and G(1) cord blood CD34+ cells for up to 24 weeks in serum-free suspension culture, containing Flt-3 ligand, thrombopoietin and stem cell factor. By week 24, there is more than a 1,000-fold difference in granulocyte, macrophage-colony-forming cells (GM-CFC) cumulative production between the two populations, with cultures initiated from G(0) demonstrating an amplification of 1.1 x 10(5)-1.8 x 10(6) of GM-CFC compared to 45-2.7 x 10(3) for the G(1) cells. Cells from the initial G(0) population are able to produce about 250-fold higher numbers of BFU-E than those from G(1) which translates to 3 x 10(3)-1.1 x 10(5)-fold expansion and 25-390-fold expansion for G(0) and G(1), respectively. This amplification of the progenitor cells is reflected in finding that a greater proportion of the progeny of the G(0) population are CD34+, resulting in a 600-fold expansion of CD34+ cells at week 8. As in other in vitro systems, total cell expansion is less discriminatory of stem cell behavior than progenitor cells, and there is no significant difference in total cell numbers between G(0) and G(1) cultures with a mean fold expansion of 2 x 10(7) at 24 weeks.
- 1 November 2001
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 19 (6) , 505-513
Cord Blood G0CD34+Cells Have A Thousand‐Fold Higher Capacity For Generating Progenitors In Vitro Than G1CD34+Cells
We examined the functional differences between G(0) and G(1) cord blood CD34+ cells for up to 24 weeks in serum-free suspension culture, containing Flt-3 ligand, thrombopoietin and stem cell factor. By week 24, there is more than a 1,000-fold difference in granulocyte, macrophage-colony-forming cells (GM-CFC) cumulative production between the two populations, with cultures initiated from G(0) demonstrating an amplification of 1.1 x 10(5)-1.8 x 10(6) of GM-CFC compared to 45-2.7 x 10(3) for the G(1) cells. Cells from the initial G(0) population are able to produce about 250-fold higher numbers of BFU-E than those from G(1) which translates to 3 x 10(3)-1.1 x 10(5)-fold expansion and 25-390-fold expansion for G(0) and G(1), respectively. This amplification of the progenitor cells is reflected in finding that a greater proportion of the progeny of the G(0) population are CD34+, resulting in a 600-fold expansion of CD34+ cells at week 8. As in other in vitro systems, total cell expansion is less discriminatory of stem cell behavior than progenitor cells, and there is no significant difference in total cell numbers between G(0) and G(1) cultures with a mean fold expansion of 2 x 10(7) at 24 weeks.